CEDIE   05498
CENTRO DE INVESTIGACIONES ENDOCRINOLOGICAS "DR. CESAR BERGADA"
Unidad Ejecutora - UE
congresos y reuniones científicas
Título:
Development of a LC-MS/MS method to measure simultaneously 10 sexual steroids in pediatric endocrinology
Autor/es:
AMBAO V; BALLERINI MG; ROPELATO MG; RODRÍGUEZ ME ; BERGADÁ I; ALTUBE M; REY RA
Lugar:
Florinópolis
Reunión:
Congreso; XXVIII Latin American Congress of Pediatric Endocrinology 2019 Annual Meeting of the Latin American Society for Pediatric Endocrinology (SLEP); 2019
Institución organizadora:
Sociedad Latinoamericana de Endocrinología Pediátrica
Resumen:
Mass spectrometry (MS) allow the determination of a panel of steroids in small sample volume with superior specificity than immunoassays, important advantages in pediatric samples. Objective: To develop LC-MS/MS method to measure concomitantly Cortisol (F), Δ4-Androstenedione (Δ4-A), Dehydroepiandrosterone (DHEA), Progesterone (P4), 17OH-Progesterone (17OHP4), Pregnenolone (P5), 17OH-Pregnenolone (17OHP5), Testosterone (T), 17Estradiol (E2) and Dihydrotestosterone (DHT) in pediatric serum samples. An UHPLC-MS/MS system (Shimadzu-ABSciex QTRAP®6500) in Multiple Reaction Monitory mode (MRM) was used. Calibration curves covering pediatric ranges were used to test linearity. Internal standards were used to calculate recovery. Precision and bias were evaluated with human serum quality controls (Biorad). F, Δ4-A, DHEA, P4, 17OHP4, P5, 17OHP5, T, and E2 could be measured by APCI+ ionization; measurement of DHT resulted to be more sensitive by ESI+ ionization. Two MRM transitions per analyte (qualitative and quantitative), compound and source parameters were optimized. A 13-min (APCI) and 8-min gradient (ESI) allowing the separation without interferences were used. Sample preparation shown recoveries between 90 and 105%. All curves shown linearity within the concentration range studied (r>0.99). LLD (signal/noise ratio=3) and LLQ (signal/noise=10) were: F: 0.013, 0.044 ug/dl, Δ4-A: 0.41, 1.37 ng/ml, DHEA: 0.37, 1.22 ng/ml, P4: 0.025, 0.08 ng/ml, 17OHP4: 0.005, 0.018 ng/ml, P5: 0.23, 0.76 ng/ml, 17OHP5: 1.95, 6.49 ng/ml, T: 0.56, 1.87 ng/ml, E2: 20.5, 69 pg/ml, DHT: 0.13, 43 pg/ml, respectively. CV% lower than 5% were obtained in the reportable pediatric range for F, Δ4-A, T, DHEA, 17OHP4 and P4. Conclusions: A sensitive and selective clinical research LC-MS/MS method has been developed for concomitantly measurement of 10 sexual steroids in serum. Estradiol measurement performance must be improved in terms of sensitivity to be applied in pediatric setting